20:19 IST
NSE
Dividend
AstraZeneca Pharma India Dividend
AstraZeneca Pharma India Limited has fixed July 31, 2026, as the record date for determining shareholder entitlement for the final dividend for financial year 2025-26.
AstraZeneca Pharma India Ltd
- Share price
- ₹5,918.00
- Market cap
- ₹14,795 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 87.2×Sector 47.3×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 8Regulatory Approval 6Legal & Regulatory 6Other Announcement 5Annual General Meeting 4Financial Results 3Results Update 2Dividend 2Board Meeting Date 2Capacity Expansion 1Business Update 1Annual Report 1Adverse Business Impact 1
Time
2 announcements with these filters
20:01 IST
NSE
Dividend
AstraZeneca Pharma India Dividend
AstraZeneca Pharma India recommended a final dividend of ₹24 per equity share for FY 2025-26. The payout is subject to shareholder approval at the August AGM.